DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fabrazyme (Agalsidase Beta) - Cardiac Disorder - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cardiac Disorder (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fabrazyme (Agalsidase Beta) where reactions include cardiac disorder. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Fabrazyme side effects in male

Reported by a pharmacist from United States on 2012-08-03

Patient: male

Reactions: Adverse Event, Cardiac Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in male

Reported by a physician from Brazil on 2012-05-11

Patient: male

Reactions: Renal Injury, Renal Disorder, Furuncle, Drug Administration Error, Pyrexia, Cushing's Syndrome, Cardiac Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme

Other drugs received by patient: Corticosteroids



Possible Fabrazyme side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-05-04

Patient: male

Reactions: Renal Disorder, Cushing's Syndrome, Cardiac Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme

Other drugs received by patient: Corticosteroids



Possible Fabrazyme side effects in female

Reported by a physician from United States on 2012-02-17

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Weight Decreased, Perforated Ulcer, Asthenia, Gastric Disorder, Cardiac Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 1 mg/kg, q2w
    Start date: 2006-11-16

Fabrazyme
    Dosage: unk
    Indication: Fabry's Disease

Other drugs received by patient: Furosemide; Iron; Aspirin; Zyrtec; Carvedilol; Symbicort; Multi-Vitamin; Sotalol HCL; Calcium Carbonate; Vitamin D; Flora-Q; Spiriva; Fioricet; Protonix; Magnesium Oxide



Possible Fabrazyme side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-03

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Ear Pain, Fall, Cardiac Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-22

Patient: male

Reactions: Death, Cardiac Disorder

Adverse event resulted in: death

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in

Reported by a consumer/non-health professional from United States on 2011-10-31

Patient:

Reactions: Cardiac Disorder

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in male

Reported by a consumer/non-health professional from United States on 2011-10-18

Patient: male

Reactions: Cardiac Disorder

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in male

Reported by a consumer/non-health professional from Australia on 2011-10-18

Patient: male

Reactions: Cardiac Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fabrazyme



Possible Fabrazyme side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-17

Patient:

Reactions: Weight Decreased, Fatigue, Renal Failure, Gastrointestinal Disorder, Ejection Fraction Decreased, Pain, Cardiac Disorder

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 0.5 mg/kg, q2w
    Indication: Fabry's Disease
    Start date: 2010-09-08

Fabrazyme
    Dosage: 0.9 mg/kg, q2w
    Start date: 2001-07-31

Other drugs received by patient: Mycophenolate Mofetil (Cellcept); Lorcet-HD; Roxicet; Magnesium Oxide; Prograf; Aspirin



Possible Fabrazyme side effects in

Reported by a physician from United States on 2011-10-03

Patient:

Reactions: Weight Decreased, Renal Failure, Fatigue, Gastrointestinal Disorder, Pain, Ejection Fraction Decreased, Cardiac Disorder

Drug(s) suspected as cause:
Fabrazyme
    Dosage: 0.5 mg/kg, q2w
    Indication: Fabry's Disease
    Start date: 2010-09-08

Fabrazyme
    Dosage: 0.9 mg/kg, q2w
    Start date: 2001-07-31

Other drugs received by patient: Magnesium Oxide; Aspirin; Prograf; Roxicet; Lorcet-HD; Mycophenolate Mofetil (Cellcept)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017